Just wanted to say — for anyone reading this Novo Nordisk vs Eli thread who is feeling discouraged: it gets better. The first month are the hardest. Hang in there. 💪

As a healthcare provider, I want to add some clinical context to this discussion on Novo Nordisk vs Eli Lilly the GLP-1.

Building on what anders_CPH said — the evidence base here is well-established. The key publications to reference are from the FLOW program[1].

Key clinical points:

1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
2. Side effect profile is predictable and usually manageable with standard protocols
3. Monitoring should include baseline labs and follow-up at 3-month intervals
4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

Subscribing to this thread. Novo Nordisk vs Eli Lilly is exactly what I've been researching. 🙏

Want to share my personal experience related to Novo Nordisk vs Eli Lilly the since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 251 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 16 months later: I am down 61 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The Novo Nordisk vs Eli aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.

+1 to PurityPaulOR. Especially the point about "The first month are the hardest..." — I have seen the same in my own experience with Novo Nordisk vs Eli Lilly.